Indaptus Therapeutics, Inc. (INDP)

Indaptus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	13.36	9.63	39.13	1.64	9.29
Short-Term Investments	0	16.81	0	0	0.77
Cash & Cash Equivalents	13.36	26.43	39.13	1.64	10.06
Cash Growth	-49.45%	-32.45%	2289.75%	-83.73%	-75.20%
Other Current Assets	0.63	0.81	1.26	0.09	3.68
Total Current Assets	14	27.24	40.39	1.73	13.75
Property, Plant & Equipment	0.17	0.08	0.17	0	3.82
Other Long-Term Assets	0.75	0.74	0.02	0.04	3.72
Total Long-Term Assets	0.93	0.82	0.19	0.05	7.54
Total Assets	14.92	28.06	40.58	1.78	21.28
Accounts Payable	2.67	3.35	4.51	0.6	3.51
Current Debt	0.1	0.08	0.1	1.42	0
Other Current Liabilities	0	0	0	0	4.84
Total Current Liabilities	2.77	3.43	4.6	2.02	8.34
Long-Term Debt	0.07	0	0.07	0	0.8
Other Long-Term Liabilities	0	0	0	0	0.6
Total Long-Term Liabilities	0.07	0	0.07	0	1.4
Total Liabilities	2.85	3.43	4.68	2.02	9.75
Total Debt	0.18	0.08	0.17	1.42	0.8
Debt Growth	117.47%	-52.46%	-88.05%	77.36%	-
Retained Earnings	-45.42	-29.99	-15.67	-7.96	-189.42
Comprehensive Income	0	0.1	0	0	0
Shareholders' Equity	12.08	24.63	35.9	-0.24	11.54
Net Cash / Debt	13.19	26.35	38.96	0.22	9.26
Net Cash / Debt Growth	-49.96%	-32.37%	17580.65%	-97.62%	-77.17%
Net Cash Per Share	1.57	3.19	9.52	0.11	21.94
Working Capital	11.22	23.81	35.78	-0.28	5.4
Book Value Per Share	1.44	2.98	8.78	-0.12	27.32

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).